UPDATED Sep 11, 2025
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
NERV | US$2.13 | -7.8% | -22.5% | US$15.0m | n/a | PE1.3x | n/a | n/a | ||
ATHA | US$0.38 | -1.3% | -25.0% | US$15.0m | n/a | PB0.5x | E28.6% | n/a | ||
SILVAPHL | ৳13.40 | 5.5% | -3.6% | ৳1.8b | n/a | PS4.2x | n/a | 0.7% | ||
A233250 | ₩12,000.00 | -6.3% | -14.2% | ₩21.0b | n/a | n/a | n/a | n/a | ||
IXI | UK£0.12 | 1.3% | 26.3% | UK£11.1m | n/a | PS1.7x | E-19.9% | n/a | ||
ATORX | SEK 4.04 | -2.3% | -99.7% | SEK 140.6m | SEK 19.00 | PS3.2x | E59.1% | n/a | ||
ALVAL | €0.81 | 1.9% | -40.6% | €12.9m | €3.00 | PS73.3x | E42.7% | n/a | ||
CYCC | US$6.37 | -14.7% | -97.5% | US$15.2m | n/a | PS1425.1x | n/a | n/a | ||
BDX | AU$0.063 | 3.3% | -42.7% | AU$23.1m | n/a | PS8.7x | n/a | n/a | ||
537536 | ₹97.93 | -1.1% | -41.5% | ₹1.4b | n/a | n/a | n/a | 2.6% | ||
CMMB | US$3.05 | 0% | -61.9% | US$15.5m | US$29.67 | PB1.6x | E-18.8% | n/a | ||
FA0 | €0.015 | -17.1% | -51.0% | €13.3m | n/a | PS11.3x | n/a | n/a | ||
A322970 | ₩2,175.00 | 3.6% | 26.5% | ₩21.9b | n/a | n/a | n/a | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
KLAR | SEK 0.60 | -2.0% | -22.8% | SEK 146.6m | SEK 1.00 | PS13.2x | E82.4% | n/a | ||
PAR | ₹113.57 | 14.1% | -56.3% | ₹1.4b | n/a | PE9.9x | n/a | 0% | ||
532384 | ₹136.50 | -0.2% | -25.1% | ₹1.4b | n/a | PE11.5x | n/a | 2.2% | ||
SOTAC | ₹126.40 | -3.3% | -15.8% | ₹1.4b | n/a | PE31.3x | n/a | 0% | ||
VSC | €1.18 | 130.5% | -77.7% | €13.5m | n/a | PS63.7x | n/a | n/a | ||
CLRB | US$5.28 | 6.0% | -91.7% | US$16.0m | US$47.00 | PB3x | E23.3% | n/a | ||
MODTX | SEK 1.23 | 6.5% | -31.6% | SEK 149.0m | n/a | PE-9.8x | E59.1% | n/a | ||
PHIL | د.أ1.52 | 0.7% | n/a | د.أ11.4m | n/a | PE12.5x | n/a | 4.6% | ||
7607 | NT$16.05 | -8.3% | -41.2% | NT$490.4m | n/a | n/a | n/a | n/a | ||
SHRX | CA$0.75 | -25.0% | n/a | CA$22.5m | n/a | PB6.6x | n/a | n/a |